BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31098818)

  • 1. Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.
    Sugano D; Sidana A; Jain AL; Calio B; Gaur S; Maruf M; Merino M; Choyke P; Turkbey B; Wood BJ; Pinto PA
    Int Urol Nephrol; 2019 Aug; 51(8):1349-1355. PubMed ID: 31098818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
    Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
    AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy.
    Jang WS; Kim LH; Yoon CY; Rha KH; Choi YD; Hong SJ; Ham WS
    PLoS One; 2016; 11(10):e0164497. PubMed ID: 27716842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
    Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA
    Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of seminal vesicle invasion on preoperative multi-parametric magnetic resonance imaging in pathological stage T3b prostate cancer.
    Kim JK; Lee HJ; Hwang SI; Choe G; Hong SK
    Sci Rep; 2020 Mar; 10(1):5693. PubMed ID: 32231265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Sorce G; Hoeh B; Hohenhorst L; Tian Z; Saad F; Tilki D; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Oct; 20(5):e380-e389. PubMed ID: 35618597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.
    Chung DY; Koh DH; Goh HJ; Kim MS; Lee JS; Jang WS; Choi YD
    BMC Cancer; 2018 Nov; 18(1):1057. PubMed ID: 30382916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Harmon SA; Gesztes W; Young D; Mehralivand S; McKinney Y; Sanford T; Sackett J; Cullen J; Rosner IL; Srivastava S; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Dobi A; Sesterhenn IA; Turkbey B
    Radiology; 2021 Jun; 299(3):613-623. PubMed ID: 33847515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
    Dominguez C; Plata M; Cataño JG; Palau M; Aguirre D; Narvaez J; Trujillo S; Gómez F; Trujillo CG; Caicedo JI; Medina C
    Int Braz J Urol; 2018; 44(4):688-696. PubMed ID: 29570254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
    Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
    Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.
    Tonttila PP; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    Scand J Urol; 2018 Apr; 52(2):111-115. PubMed ID: 29291666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts.
    Ötleş E; Denton BT; Qu B; Murali A; Merdan S; Auffenberg GB; Hiller SC; Lane BR; George AK; Singh K
    J Urol; 2022 Feb; 207(2):358-366. PubMed ID: 34551595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.
    Zattoni F; Kawashima A; Morlacco A; Davis BJ; Nehra AK; Mynderse LA; Froemming AT; Jeffrey Karnes R
    Pract Radiat Oncol; 2017; 7(1):42-49. PubMed ID: 27527896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.